Seo Hyejin, Jung Boyoung, Yeo Jiyoon, Kim Koh-Woon, Cho Jae-Heung, Lee Yoon Jae, Ha In-Hyuk
Korean rehabilitation medicine, Jaseng Hospital of Korean Medicine, Seoul, South Korea.
Department of Health Administration, Hanyang Women's University, Seoul, South Korea.
BMJ Open. 2020 Oct 28;10(10):e036768. doi: 10.1136/bmjopen-2020-036768.
Temporomandibular joint disorder (TMD) requires long-term management and can be a financial burden for patients. Here, we investigated the treatment received by people diagnosed with TMD and its relevant costs.
A descriptive, cross-sectional study.
We performed secondary data analysis of health insurance claims data provided by the Health Insurance Assessment and Review (HIRA) of the Republic of Korea. We reviewed the records of 10 041 patients who were diagnosed with TMD and who utilised outpatient healthcare service at least once between January and December 2017.
Data on use of medical services, hospitalisations, sociodemographic factors, treatment and medication were retrieved and analysed. Cost was defined as the cost of care incurred by a health insurance beneficiary at a care facility.
We reported the characteristics as medians, frequencies and percentages and found that most TMD patients were outpatients, women (58.9%) and in their 20s (46.4%). For visit type, 85.9% of all patients had an outpatient dental medical visit, with most visiting dental clinics and dental hospitals. Western medicine (WM; 9.8%) was prescribed more often, followed by Korean medicine (KM; 8.2%). The median expense per patient was highest among those in their 20s (58.00, 23.90, 53.40, 65.90 US$ for overall, WM, dental medicine (DM) and KM, respectively). Consultation fees accounted for the greatest percentage (42.8%) of DM and WM care expenses, while injection/non-surgical intervention fees accounted for the greatest percentage of KM care expenses. The most commonly used treatments for TMD were temporomandibular joint stimulation therapy (51.1%) and acupuncture (19.9%), considered as the most basic care for TMD. Psychosomatic agents (86.4%) were the most commonly used medications in outpatients.
While people with TMD most commonly received temporomandibular stimulation therapy, the costs and duration of treatment varied significantly for these patients.
颞下颌关节紊乱病（TMD）需要长期管理，且可能给患者带来经济负担。在此，我们调查了被诊断为TMD的患者所接受的治疗及其相关费用。
一项描述性横断面研究。
我们对大韩民国健康保险评估与审查机构（HIRA）提供的健康保险理赔数据进行了二次数据分析。我们查阅了2017年1月至12月期间被诊断为TMD且至少使用过一次门诊医疗服务的10041名患者的记录。
检索并分析了关于医疗服务使用、住院情况、社会人口学因素、治疗和用药的数据。费用定义为健康保险受益人在医疗机构产生的护理费用。
我们以中位数、频率和百分比的形式报告了相关特征，发现大多数TMD患者为门诊患者，女性（58.9%）且年龄在20多岁（46.4%）。就就诊类型而言，所有患者中有85.9%进行了门诊牙科医疗就诊，大多数前往牙科诊所和牙科医院。西医（WM；9.8%）的处方开具频率更高，其次是韩医（KM；8.2%）。20多岁患者的人均费用中位数最高（总体、西医、牙科医学（DM）和韩医分别为58.00、23.90、53.40、65.90美元）。咨询费在DM和WM护理费用中占比最大（42.8%），而注射/非手术干预费在KM护理费用中占比最大。TMD最常用的治疗方法是颞下颌关节刺激疗法（51.1%）和针灸（19.9%），被视为TMD最基本的治疗方法。心身药物（86.4%）是门诊患者最常用的药物。
虽然TMD患者最常接受颞下颌刺激疗法，但这些患者的治疗费用和疗程差异很大。
